Correction: Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups (Molecular Psychiatry, (2020), 25, 11, (2942-2951), 10.1038/s41380-018-0298-8);Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups

Molecular Psychiatry

Volumn 25, Issue 11, 2020, Pages 2942-2951

  Mukherjee, Shubhabrata ^a   Mez, Jesse ^b   Trittschuh, Emily H ^a,c   Saykin, Andrew J ^d   Gibbons, Laura E ^a   Fardo, David W ^e   Wessels, Madeline ^f   Bauman, Julianna ^f   Moore, Mackenzie ^f   Choi, Seo Eun ^a   Gross, Alden L ^g   Rich, Joanne ^f   Louden, Diana K N ^f   Sanders, R Elizabeth ^a   Grabowski, Thomas J ^a   Bird, Thomas D ^a,c   McCurry, Susan M ^f   Snitz, Beth E ^h   Kamboh, M Ilyas ⁱ   Lopez, Oscar L ^h   De Jager, Philip L ^j   Bennett, David A ^k   Keene, C Dirk ^a   Larson, Eric B ^a,l   Crane, Paul K ^a   more..

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^d INDIANA UNIVERSITY   (United States)

^e UNIVERSITY OF KENTUCKY   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF PITTSBURGH   (United States)

^j Department of Medicine   (United States)

^k RUSH UNIVERSITY MEDICAL CENTER   (United States)

^l KAISER PERMANENTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALZHEIMER DISEASE; CLASSIFICATION; COGNITION; EXECUTIVE FUNCTION; FEMALE; GENETICS; GENOTYPE; HUMAN; LANGUAGE; MALE; MEMORY; PSYCHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; SPATIAL ORIENTATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; COGNITION; EXECUTIVE FUNCTION; FEMALE; GENOTYPE; HUMANS; LANGUAGE; MALE; MEMORY; POLYMORPHISM, SINGLE NUCLEOTIDE; SPATIAL NAVIGATION;

EID: 85058024274     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/s41380-019-0348-x     Document Type: Erratum

References (28)

1. Lam B, Masellis M, Freedman M, Stuss DT, Black SE. Clinical, imaging, and pathological heterogeneity of the Alzheimer’s disease syndrome. Alzheimers Res Ther. 2013;5:1. DOI: 10.1186/alzrt155
2. Cholerton B, Larson EB, Quinn JF, Zabetian CP, Mata IF, Keene CD, et al. Precision medicine: clarity for the complexity of dementia. Am J Pathol. 2016;186:500–6. DOI: 10.1016/j.ajpath.2015.12.001
3. Girard SL, Rouleau GA. Genome-wide association study in FTD: divide to conquer. Lancet Neurol. 2014;13:643–4.
4. Crane PK, Trittschuh E, Mukherjee S, Saykin AJ, Sanders RE, Larson EB, et al. Incidence of cognitively defined late-onset Alzheimer’s dementia subgroups from a prospective cohort study. Alzheimer’s Dement. 2017;13:1307–16.
5. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology. 1984;34:939–44.
6. Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet. 2013;45:1452–8.
7. Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer’s disease. Nat Genet. 2011;43:436–41.
8. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412–4.
9. Muthen LK, Muthen BO. Mplus user’s guide. 7th ed. LA: Muthen & Muthen; 1998–2012.
10. Manichaikul A, Mychaleckyj JC, Rich SS, Daly K, Sale M, Chen WM. Robust relationship inference in genome-wide association studies. Bioinformatics. 2010;26:2867–73. DOI: 10.1093/bioinformatics/btq559
11. Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4:7. DOI: 10.1186/s13742-015-0047-8
12. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26:2190–1. DOI: 10.1093/bioinformatics/btq340
13. Schott JM, Crutch SJ, Carrasquillo MM, Uphill J, Shakespeare TJ, Ryan NS, et al. Genetic risk factors for the posterior cortical atrophy variant of Alzheimer’s disease. Alzheimers Dement. 2016;12:862–71. DOI: 10.1016/j.jalz.2016.01.010
14. El Haj M, Antoine P, Amouyel P, Lambert JC, Pasquier F, Kapogiannis D. Apolipoprotein E (APOE) epsilon4 and episodic memory decline in Alzheimer’s disease: a review. Ageing Res Rev. 2016;27:15–22. DOI: 10.1016/j.arr.2016.02.002
15. DeMichele-Sweet MAA, Weamer EA, Klei L, Vrana DT, Hollingshead DJ, Seltman HJ, et al. Genetic risk for schizophrenia and psychosis in Alzheimer disease. Mol Psychiatry. 2017;23:963–72. DOI: 10.1038/mp.2017.81
16. Sherva R, Tripodis Y, Bennett DA, Chibnik LB, Crane PK, de Jager PL, et al. Genome-wide association study of the rate of cognitive decline in Alzheimer’s disease. Alzheimers Dement. 2014;10:45–52. DOI: 10.1016/j.jalz.2013.01.008
17. Scheltens NM, Galindo-Garre F, Pijnenburg YA, van der Vlies AE, Smits LL, Koene T, et al. The identification of cognitive subtypes in Alzheimer’s disease dementia using latent class analysis. J Neurol Neurosurg Psychiatry. 2016;87:235–43. DOI: 10.1136/jnnp-2014-309582
18. Scheltens NME, Tijms BM, Koene T, Barkhof F, Teunissen CE, Wolfsgruber S, et al. Cognitive subtypes of probable Alzheimer’s disease robustly identified in four cohorts. Alzheimers Dement. 2017;13:1226–36. DOI: 10.1016/j.jalz.2017.03.002
19. Noh Y, Jeon S, Lee JM, Seo SW, Kim GH, Cho H, et al. Anatomical heterogeneity of Alzheimer disease: based on cortical thickness on MRIs. Neurology. 2014;83:1936–44. DOI: 10.1212/WNL.0000000000001003
20. Dong A, Toledo JB, Honnorat N, Doshi J, Varol E, Sotiras A, et al. Heterogeneity of neuroanatomical patterns in prodromal Alzheimer’s disease: links to cognition, progression and biomarkers. Brain. 2017;140:735–47.
21. Ossenkoppele R, Cohn-Sheehy BI, La Joie R, Vogel JW, Moller C, Lehmann M, et al. Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer’s disease. Hum Brain Mapp. 2015;36:4421–37.
22. Dickerson BC, Wolk DA. Dysexecutive versus amnesic phenotypes of very mild Alzheimer’s disease are associated with distinct clinical, genetic and cortical thinning characteristics. J Neurol Neurosurg Psychiatry. 2011;82:45–51.
23. Mez J, Mukherjee S, Thornton T, Fardo DW, Trittschuh E, Sutti S, et al. The executive prominent/memory prominent spectrum in Alzheimer’s disease is highly heritable. Neurobiol Aging. 2016;41:115–21.
24. Mukherjee S, Trittschuh E, Gibbons LE, Mackin RS, Saykin A, Crane PK, et al. Dysexecutive and amnesic AD subtypes defined by single indicator and modern psychometric approaches: relationships with SNPs in ADNI. Brain Imaging Behav. 2012;6:649–60.
25. Mez J, Cosentino S, Brickman AM, Huey ED, Manly JJ, Mayeux R. Dysexecutive versus amnestic Alzheimer disease subgroups: analysis of demographic, genetic, and vascular factors. Alzheimer Dis Assoc Disord. 2013;27:218–25.
26. Mez J, Cosentino S, Brickman AM, Huey ED, Manly JJ, Mayeux R. Faster cognitive and functional decline in Dysexecutive versus amnestic Alzheimer’s subgroups: a longitudinal analysis of the National Alzheimer’s Coordinating Center (NACC) database. PLoS One. 2013;8:e65246.
27. Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol. 2014;13:614–29.
28. Miller ZA, Mandelli ML, Rankin KP, Henry ML, Babiak MC, Frazier DT, et al. Handedness and language learning disability differentially distribute in progressive aphasia variants. Brain. 2013;136:3461–73.